Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Rectal Neoplasms × Defecation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2 Neoplasms 2 Rectal Neoplasms 1 Post-operative Ileus 1 Pancreatic Neoplasms 1 Gallbladder Neoplasms 1 Colorectal Neoplasms 1 Colonic Polyps 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1 Advanced Gastric Carcinoma 1

Interventions

Oxaliplatin 156 Capecitabine 141 Fluorouracil 131 Leucovorin 92 Radiotherapy 90 Irinotecan 79 Bevacizumab 58 Surgical Procedures, Operative 46 Drug Therapy 34 Cetuximab 31 Neoadjuvant Therapy 30 Radiation 28 Chemoradiotherapy 28 Folfox protocol 25 Chemotherapy, Adjuvant 20 XELOX 19 Radiotherapy, Intensity-Modulated 17 Proctectomy 15 Magnetic Resonance Spectroscopy 14 Surveys and Questionnaires 13 trifluridine tipiracil drug combination 11 Floxuridine 11 Early Intervention, Educational 11 Nivolumab 10 Consolidation Chemotherapy 10 Biopsy 10 regorafenib 9 Panitumumab 9 Mastectomy, Segmental 9 Immunohistochemistry 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04601727 2023-05-11

MICROBRECT

University of Aberdeen

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡